Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2026-01-26 @ 9:22 PM
Study NCT ID:
NCT00054418
Status:
COMPLETED
Last Update Posted:
2016-07-13
First Post:
2003-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03
Start Date Type:
None
Primary Completion Date:
2007-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2003-02-05
First Submit QC Date:
None
Study First Post Date:
2003-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-12
Last Update Post Date:
2016-07-13
Last Update Post Date Type:
ESTIMATED